4-(Bromomethyl)-2-chloro-1-(trifluoromethoxy)benzene → HCID 69083764, Verbindung

HRID 594579Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 594579
[CH3:1][O:2][C:3]1[CH:8]=[CH:7][CH:6]=[C:5]([O:9][CH3:10])[C:4]=1[CH:11]1[NH:16][C:15](=[O:17])[CH2:14][CH2:13][CH2:12]1.Br[CH2:19][C:20]1[CH:25]=[CH:24][C:23]([O:26][C:27]([F:30])([F:29])[F:28])=[C:22]([Cl:31])[CH:21]=1>>[Cl:31][C:22]1[CH:21]=[C:20]([CH:25]=[CH:24][C:23]=1[O:26][C:27]([F:28])([F:29])[F:30])[CH2:19][N:16]1[CH:11]([C:4]2[C:5]([O:9][CH3:10])=[CH:6][CH:7]=[CH:8][C:3]=2[O:2][CH3:1])[CH2:12][CH2:13][CH2:14][C:15]1=[O:17]

Komponenten

3

Edukt 2

HCID 27738494-(Bromomethyl)-2-chloro-1-(trifluoromethoxy)benzeneHCID 690825266-(2,6-Dimethoxyphenyl)piperidin-2-one

Produkt 1

HCID 69083764HCID 69083764, Verbindung

Versuchsvorschrift

Prepared according to the described general procedure 4 (GP4) by reaction of 6-(2,6-dimethoxyphenyl)piperidin-2-one with commercially available 4-(bromomethyl)-2-chloro-1-(trifluoromethoxy)benzene. Subsequent purification by preparative HPLC afforded the target compound. LC-MS (conditions E): tR=0.83 min.; [M+H]+: 444.11 g/mol.

Aufarbeitung

  1. customPrepared
  2. customSubsequent purification by preparative HPLC
  3. customafforded the target compound

Quellen und Nachweise

ORD-Eintrag
ord-76267b2bbca14a1c8087fabd605bd7b6
Quelldatensatz
uspto-grants-2016_01
Patentnummer
US09242970B2

Notizen zur Reaktion

Wird geladen…